<ul>
	<li>In patients with an activated renin-angiotensin-aldosterone system (RAAS), such as volume- and/or salt-depleted patients, this combination can cause excessive hypotension. Correct volume or salt depletion prior to administration of azilsartan and chlorthalidone.</li>
	<li>In patients with renal artery stenosis, This combination may cause renal failure.</li>
	<li>Monitor renal function in patients with renal impairment. Consider discontinuing this combination with progressive renal impairment.</li>
	<li>Heart rhythm problems (e.g., bradycardia, QT prolongation, ventricular tachycardia), liver problems, certain uncorrected mineral imbalances (low potassium/magnesium levels), severe kidney problems.</li>
</ul>